Bayesian Capital Management’s Enovis ENOV Stock Holding History

Bayesian Capital Management’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,351	Closed	-$983K	–	857
2022 Q1	$983K	Buy	+14,351	New	+$1.02M	0.15%	212
2020 Q4	–	Sell	-4,167	Closed	-$225K	–	515
2020 Q3	$225K	Buy	+4,167	New	+$229K	0.06%	418
2020 Q2	–	Sell	-15,090	Closed	-$514K	–	586
2020 Q1	$514K	Buy	15,090 +5,615	+59%	+$309K	0.11%	289
2019 Q4	$593K	Buy	9,475 +2,963	+46%	+$168K	0.1%	272
2019 Q3	$326K	Sell	6,512 -3,660	-36%	-$173K	0.06%	348
2019 Q2	$491K	Buy	+10,172	New	+$490K	0.1%	267
2019 Q1	–	Sell	-11,341	Closed	-$408K	–	605
2018 Q4	$408K	Buy	11,341 +59	+0.5%	+$2.75K	0.08%	333
2018 Q3	$700K	Buy	+11,282	New	+$643K	0.11%	251
2017 Q1	–	Sell	-5,501	Closed	-$340K	–	485
2016 Q4	$340K	Buy	+5,501	New	+$325K	0.08%	395

Other funds holding ENOV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bayesian Capital Management's ENOV Position: Q2 2022 in Review

Bayesian Capital Management sold out of Enovis (ENOV) in Q2 2022, closing a stake of 14,351 shares — an estimated $983K sold.

Bayesian Capital Management first reported a position in ENOV in Q4 2016 and held it in 9 quarters. The position peaked at $983K in Q1 2022. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.

Bayesian Capital Management reported no remaining Enovis position as of Q2 2022 after selling out during the quarter.
Bayesian Capital Management sold 14,351 Enovis shares in Q2 2022, an estimated $983K.
Bayesian Capital Management first reported a position in Enovis in Q4 2016 and held it in 9 quarters.
Bayesian Capital Management's Enovis position peaked at $983K in Q1 2022.
245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.